CAM
KYMR icon

Congress Asset Management’s Kymera Therapeutics KYMR Stock Holding History

Congress Asset Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-45,836
Closed -$1.84M – 371
2024
Q1 		$1.84M Buy
45,836
+533
+1% +$19.1K 0.01% 278
2023
Q4 		$1.15M Buy
45,303
+117
+0.3% +$2.09K 0.01% 311
2023
Q3 		$628K Buy
45,186
+61
+0.1% +$1.23K 0.01% 330
2023
Q2 		$1.04M Buy
45,125
+556
+1% +$15.9K 0.01% 307
2023
Q1 		$1.32M Buy
+44,569
New +$1.44M 0.01% 297

Other funds holding KYMR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return